$29.15
2.489.3%
Últ. Act.: Nov 6, 4:00 PM
The average analyst price target for Avalyn Pharma is $62, 112.7% above the current price. Of 4 analysts, 4 rate it Buy. Targets range from $51 to $80. The latest change came on Oct 2, 2026, when Raymond James initiated coverage of Avalyn Pharma with an Outperform rating and a $60 price target.
Price Target Range — 3 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months